Levofloxacina Aurobindo (Levofloxacin)

Levofloxacin inhibits two essential bacterial enzymes: DNA gyrase and topoisomerase IV. By binding to these enzymes, it blocks DNA supercoiling and strand separation, which are required for DNA replication and transcription. This disruption leads to bacterial cell death and eradication of the infection.

The dosage of Levofloxacina Aurobindo is determined by the prescribing clinician based on the specific infection, patient age, renal function, and other clinical factors. Only a qualified healthcare professional can set the appropriate dose and treatment duration.

Safety data for levofloxacin in pregnancy and lactation are limited. It is generally avoided unless the potential benefit outweighs the risk to the fetus or infant. Women who are pregnant, planning pregnancy, or breastfeeding should discuss alternatives with their healthcare provider.

To request Levofloxacina Aurobindo, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Levofloxacin offers broad‑spectrum activity against many Gram‑negative and Gram‑positive bacteria and has excellent oral bioavailability, allowing convenient oral therapy. Compared with older agents such as ciprofloxacin, it often requires once‑daily dosing and may have a more favorable side‑effect profile, but clinicians must consider resistance patterns and safety warnings.

Levofloxacina Aurobindo should be stored at temperatures below 25 °C, in its original packaging, protected from moisture and direct sunlight. Keeping the product in a dry, cool place helps maintain its potency throughout its shelf life.

Levofloxacina Aurobindo is administered orally, typically as a tablet or oral suspension, depending on the marketed form. It should be taken with a full glass of water, and patients are advised not to take it simultaneously with antacids containing aluminum or magnesium, which can impair absorption.

Serious adverse events linked to levofloxacin include tendon rupture or inflammation, QT interval prolongation that can cause cardiac arrhythmias, severe allergic reactions such as anaphylaxis, and Clostridioides difficile‑associated colitis. Patients should be instructed to report any sudden tendon pain, palpitations, or severe rash immediately.

Levofloxacina Aurobindo should be avoided in individuals with a known hypersensitivity to levofloxacin or any fluoroquinolone, patients with a history of tendon disorders related to fluoroquinolone use, and those with certain cardiac conditions that predispose to QT prolongation. Clinicians must evaluate each patient’s medical history before prescribing.